Skip to main content
. 2020 Jan;21(1):46–55. doi: 10.2174/1389202920666191210111849

Table 1. Shows the clinicopathological factors in different groups of the study.

- Malignant (HCC)
N (%)
CHC
(HCV)
N (%)
Healthy Control
N (%)
P χ2(a)
Age:
≥ 57.8
< 57.8
35 (58.3%)
25 (41.7%)
21 (50%)
21 (50%)
9 (50%)
9 (50%)
.657 NS 0.839
Sex:
Male (88)
Female (32)
43 (71.7%)
17 (28.3%)
33 (78.6%)
9 (21.4%)
12 (66.7%)
6 (33.3%)
.582 NS 1.084
Smoking:
Smoker (53)
Non-Smoker (67)
23 (38.3%)
37 (61.7%)
21 (50%)
21 (50%)
9 (50%)
9 (50%)
.437 NS 1.656
HCV-antibodies:
Positive (94)
Negative (26)
52 (86.7%)
8 (13.3%)
42 (100%)
0 (0%)
0 (0%)
18 (100%)
.000** 79.149
HBV-sAg:
Positive(6)
Negative(114)
6 (10%)
54 (90%)
0 (0%)
42 (100%)
0 (0%)
18 (100%)
.043* 6.316
Cirrhosis:
Cirrhotic(70)
Non-cirrhotic(50)
49(81.7%)
11(18.3%)
9(21.4%)
33(78.6%)
0(0%)
18(100%)
.000** 39.840